PMV Pharmaceuticals, Inc.

US$1.26As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PMVPHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (42.12%)
Div yield —
ROE (70.93%)
Biotechnology
Beta (5Y) 1.51
PE TTM —
TSR TTM (10.64%)
Mkt cap US$95.15M
ROIC (46.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.37
8.98%
(9.04%)
Hold 7|10|12|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
9.72%
9.84%
(2.49%)
8.00%
Revenue$M
10.19
10.00
10.38
10.60
13.37%
8.50%
6.48%
2.70%
Peers (US$95.15M)
Cap (US$)
PE
94.71M
90.59x
Capital
TTM
5Y
10Y
Leveragex
2.387
(0.035)
(0.036)
EBIT/Intx
2.460
0.692
0.572
Own earn%
75.83
62.09
63.43
Sh yield%
30.07
16.33
18.69
Owners
Insiders/Inst%
2.18
28.99
Short interest%
1.27
SBC / revenue%
2.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
13–17
$1 testx
0.2
Incr. ROIC%
30